enGene Holdings Inc. (ENGN)

enGene Holdings Statistics

Total Valuation

enGene Holdings has a market cap or net worth of $625.64 million. The enterprise value is $463.70 million.

Market Cap	625.64M
Enterprise Value	463.70M

Important Dates

The next estimated earnings date is Monday, March 9, 2026, after market close.

Earnings Date	Mar 9, 2026
Ex-Dividend Date	n/a

Share Statistics

enGene Holdings has 66.98 million shares outstanding. The number of shares has increased by 35.30% in one year.

Current Share Class	66.98M
Shares Outstanding	66.98M
Shares Change (YoY)	+35.30%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	32.23%
Float	32.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.90
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.19.

Current Ratio	6.30
Quick Ratio	6.13
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.14

Financial Efficiency

Return on equity (ROE) is -53.28% and return on invested capital (ROIC) is -30.97%.

Return on Equity (ROE)	-53.28%
Return on Assets (ROA)	-28.90%
Return on Invested Capital (ROIC)	-30.97%
Return on Capital Employed (ROCE)	-65.00%
Revenue Per Employee	n/a
Profits Per Employee	-$1.43M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.81% in the last 52 weeks. The beta is -0.28, so enGene Holdings's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+30.81%
50-Day Moving Average	8.30
200-Day Moving Average	5.69
Relative Strength Index (RSI)	59.00
Average Volume (20 Days)	278,271

Short Selling Information

The latest short interest is 1.50 million, so 2.24% of the outstanding shares have been sold short.

Short Interest	1.50M
Short Previous Month	1.13M
Short % of Shares Out	2.24%
Short % of Float	4.56%
Short Ratio (days to cover)	5.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-123.17M
Pretax Income	-117.30M
Net Income	-117.30M
EBITDA	-122.66M
EBIT	-123.17M
Earnings Per Share (EPS)	-$2.29

Balance Sheet

The company has $193.74 million in cash and $31.80 million in debt, with a net cash position of $161.94 million or $2.42 per share.

Cash & Cash Equivalents	193.74M
Total Debt	31.80M
Net Cash	161.94M
Net Cash Per Share	$2.42
Equity (Book Value)	167.71M
Book Value Per Share	3.22
Working Capital	169.41M

Cash Flow

In the last 12 months, operating cash flow was -$99.24 million and capital expenditures -$1.49 million, giving a free cash flow of -$100.72 million.

Operating Cash Flow	-99.24M
Capital Expenditures	-1.49M
Free Cash Flow	-100.72M
FCF Per Share	-$1.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

enGene Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.30%
Shareholder Yield	-35.30%
Earnings Yield	-18.75%
FCF Yield	-16.10%

Analyst Forecast

The average price target for enGene Holdings is $22.71, which is 143.15% higher than the current price. The consensus rating is "Buy".

Price Target	$22.71
Price Target Difference	143.15%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2